Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
This article simplifies altcoins that beginners find approachable, outlining key features, how they differ from BTC, and practical steps to research safely.
20,932 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Shoppers cut back on fuel purchases as pump prices stay elevated, signaling tighter household budgets. Walmart’s fina...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
Oil hovered around $104 per barrel on May 22, 2026, after a slip from the prior session. Analysts say supply discipli...
Target stock faces a pivotal test as margins and non-merchandise revenue drive valuation. With 2027 upside priced int...
When a spouse dies, the surviving widow’s Social Security check often replaces the couple’s two payments with a singl...
A surge in quantum-tech optimism helped lift IonQ shares even without direct news from the company. Here’s what happe...
A Philadelphia primary delivers a surprise win for a self-described 'proud troublemaker' democratic socialist, beatin...
A 64-year-old retiree drains $1.1 million from a 401(k) to maximize Social Security at age 70, highlighting a content...
Starting with $1,000? This guide shows how to identify the ultimate dividend stock with durable payouts, build a smal...
As volatility tests investors, three utility ETFs offer steady income with defensive exposure. Here’s how XLU, VPU, a...
A blockbuster SpaceX IPO could reshape markets, but history shows the real winners are the infrastructure players beh...